Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: A retrospective observational study

Alexandra Steck,Joyce Barlin,Patrick Timmins, Timothy McElrath, Jovana Martin

GYNECOLOGIC ONCOLOGY（2023）

引用 0|浏览2

暂无评分

摘要

To report on the efficacy of pembrolizumab, bevacizumab, and oral metronomic cyclophosphamide used in combination among patients with platinum-resistant recurrent ovarian cancer in community practice.

查看译文

关键词

resistant recurrent ovarian cancer,ovarian cancer,pembrolizumab,oral metronomic cyclophosphamide,bevacizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要